Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTA) Other Operating Expenses (2019 - 2025)

Strata Critical Medical (SRTA) has disclosed Other Operating Expenses for 7 consecutive years, with -$100.7 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses fell 13.44% to -$100.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $35.9 million through Dec 2025, down 4.45% year-over-year, with the annual reading at $2.6 million for FY2025, 235.2% up from the prior year.
  • Other Operating Expenses for Q4 2025 was -$100.7 million at Strata Critical Medical, down from $38.2 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $58.5 million in Q3 2023, with the low at -$100.7 million in Q4 2025.
  • Average Other Operating Expenses over 5 years is $11.3 million, with a median of $27.2 million recorded in 2022.
  • The sharpest move saw Other Operating Expenses surged 5676.89% in 2021, then crashed 317.23% in 2024.
  • Over 5 years, Other Operating Expenses stood at -$22.1 million in 2021, then plummeted by 40.23% to -$31.0 million in 2022, then soared by 232.04% to $40.9 million in 2023, then tumbled by 317.23% to -$88.8 million in 2024, then fell by 13.44% to -$100.7 million in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at -$100.7 million, $38.2 million, and $54.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.